BRCA2 and neoplasm: In the previous study, Marcheselli et al. [2] demonstrated that human epidermal growth factor receptor 2 (HER-2) positivity, and BRCA1 or BRCA2 mutation had an effect on the risk of second primary neoplasms, but the effect was not limited to TC.